Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm

Human Molecular Genetics

Volumn 19, Issue 9, 2010, Pages 1651-1668

  Royer Pokora, Brigitte ^a   Busch, Maike ^a   Beier, Manfred ^a   Duhme, Constanze ^a   de Torres, Carmen ^b   Mora, Jaume ^b   Brandt, Artur ^a   Royer, Hans Dieter ^a,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA CATENIN; ENDOGLIN; MOLECULAR MARKER; PROTEIN CTNNB1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR 7 LIKE 2; TUMOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WT1 PROTEIN;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CHILD; CHONDROGENESIS; CHROMOSOME 11P; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE NUMBER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INFANT; KARYOTYPE; MALE; MESENCHYMAL STEM CELL; MESODERM; MITOTIC RECOMBINATION; MUSCLE DEVELOPMENT; NEPHROBLASTOMA; NEUROECTODERM; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL;

AMINO ACID SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 11; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; LYMPHOID ENHANCER-BINDING FACTOR 1; MESENCHYMAL STEM CELLS; MESODERM; MOLECULAR SEQUENCE DATA; MUTATION; WILMS TUMOR;

EID: 77952538909     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq042     Document Type: Article

References (60)

1. Beckwith, J.B., Kiviat, N.B. and Bonadio, J.F. (1990) Nephrogenic rests, nephroblastomatosis and the pathogenesis of Wilms tumor. Pediatr. Pathol., 10, 1-36.
2. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. and Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
3. Schumacher, V., Schneider, S., Figge, A., Wildhardt, G., Harms, D., Schmidt, D., Weirich, A., Ludwig, R. and Royer-Pokora, B. (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc. Natl Acad. Sci. USA, 94, 3972-3977.
4. Miyagawa, K., Kent, J., Moore, A., Charlieu, J.P., Little, M.H., Williamson, K.A., Kelse, A., Brown, K.W., Hassam, S., Briner, J. et al. (1998) Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour. Nat. Genet., 18, 5-17.
5. Nakadate, H., Yokomori, K., Watanabe, N., Tsuchiya, T., Namiki, T., Kobayashi, H., Suita, S., Tsunematsu, Y., Horikoshi, Y., Hatae, Y. et al. (2001) Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan. Int. J. Cancer, 94, 396-400.
6. Shibata, R., Takata, A., Hashiguchi, A., Umezawa, A., Yamada, T. and Hata, J. (2003) Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor. Pathol. Int., 53, 214-220.
7. Schumacher, V., Schuhen, S., Sonner, S., Weirich, A., Leuschner, I., Harms, D., Licht, J., Roberts, S. and Royer-Pokora, B. (2003) Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Clin. Cancer Res., 9, 2005-2014.
8. Fukuzawa, R., Heathcott, R.W., Sano, M., Morison, I.M., Yun, K. and Reeve, A.E. (2004) Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signalling pathway. Ped. Dev. Pathol., 7, 125-137.
9. Fukuzawa, R., Heathcott, R.W., More, H.E. and Reeve, A.E. (2007) Sequential WT1 and CTNNB1 mutations and alterations of b-catenin localisation in intralabor nephrogenic rests and associated Wilms tumours: two case studies. J. Clin. Pathol., 60, 1013-1016.
10. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D. et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature, 346, 194-197.
11. Koesters, R., Ridder, R., Kopp-Schneider, A., Betts, D., Adams, V., Niggli, F., Briner, J. and von Knebel Doeberitz, M. (1999) Mutational activation of the β-catenin Proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res., 59, 3880-3882.
12. Maiti, S., Alam, R., Amos, C.I. and Huff, V. (2000) Frequent association of β-catenin and WT1 mutations in Wilms tumors. Cancer Res., 60, 6288-6292.
13. Li, C.-M., Kim, C.E., Margolin, A.A., Guo, M., Zhu, J., Mason, J.M., Hensle, T.W., Murty, V.V.V.S., Grundy, P.E., Fearon, E.R. et al. (2004) CTNNB1 mutations and overexpression of Wnt//β-catenin target genes in WT1-mutant Wilms' tumors. Am. J. Pathol., 165, 1943-1953.
14. Royer-Pokora, B., Weirich, A., Schumacher, V., Uschkereit, C., Beier, M., Leuschner, I., Graf, N., Autschbach, F., Schneider, D. and von Harrach, M. (2008) Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology. Cancer, 113, 1080-1089.
15. Ravenel, J.D., Broman, K.W., Perlman, E.J., Niemitz, E.L., Jayawardena, T.M., Bell, D.W., Haber, D.A., Uejima, H. and Feinberg, A.P. (2001) Loss of imprinting of insulin-like groth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl. Cancer Inst., 93, 1698-1703.
16. Oliver, J., Barasch, J., Yang, J., Herzlinger, D. and Al-Awqat, Q. (2002) Mesenchyme contains embryonic renal stem cells. Am. J. Physiol. Renal Physiol., 283, F799-F809.
17. Herzlinger, D., Koseki, C., Mikawa, T. and Al-Awqati, Q. (1992) Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development, 114, 565-572.
18. Qiao, J., Cohen, D. and Herzlinger, D. (1995) The metanephric blastema differentiates into collecting system and nephron epithelia in vitro. Development, 121, 3207-3214.
19. - multipotent stem/progenitor cells from adult mouse kidney. J. Am. Soc. Nephrol., 17, 3300-3314.
20. Challen, G.A., Bertoncello, I., Deane, J.A., Ricardo, S.D. and Little, M.H. (2006) Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J. Am. Soc. Nephrol., 17, 1896-1912.
21. Bussolati, B., Bruno, S., Grange, C., Buttiglieri, S., Deregibus, M.C., Cantino, D. and Camussi, G. (2005) Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol., 166, 545-555.
22. Hatini, V., Huh, S.O., Herzlinger, D., Soares, V.C. and Lai, E. (1996) Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of winged helix transcription factor BF-2. Genes Dev., 10, 1467-1478.
23. Levinson, R.S., Batourina, E., Choi, C., Vorontchikhina, M., Kitajewski, J. and Mendelsohn, C.L. (2005) Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development, 132, 529-539.
24. Guillaume, R., Bressan, M. and Herzlinger, D. (2009) Paraxial mesoderm contributes stromal cells to the developing kidney. Dev. Biol., 329, 169-175.
25. Engleka, K.A., Gitler, A.D., Zhang, M., Zhou, D.D., High, F.A. and Epstein, J.A. (2005) Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivates. Dev. Biol., 280, 396-406.
26. Garvin, A.J., Surrette, F., Hintz, D.S., Rudisill, M.T., Sens, M.A. and Sens, D.A. (1985) The in vitro growth and characterization of the skeletal muscle component of Wilms' tumor. Am. J. Pathol., 121, 298-310.
27. Garvin, A.J., Sullivan, J.L., Bennett, D.D., Stanley, W.S., Inabnett, T. and Sens, D.A. (1987) The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor. Am. J. Pathol., 129, 353-363.
28. Hazen-Martin, D.J., Garvin, J., Gansler, T., Tarnowski, B.I. and Sens, D.A. (1993) Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am. J. Pathol., 142, 893-905.
29. Hazen-Martin, D.J., Re, G.G., Garvin, A.J. and Sens, D.A. (1994) Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am. J. Pathol., 144, 1023-1034.
30. Löbbert, R.W., Klemm, G., Grüttner, H.-P., Harms, D., Winterpracht, A. and Zabel, B.U. (1998) Novel WT1 mutation, 11p LOH, and t(7;12)(p22;q22) chromosomal translocation identified in a Wilms' tumor case. Genes Chromosomes Cancer, 21, 347-350.
31. Alami, J., Williams, B.R. and Yeger, H. (2003) Derivation and characterization of a Wilms' tumor cell line, WiT 49. Int. J. Cancer, 107, 365-374.
32. Haber, D.A., Park, S., Maheswaran, S., Englert, C., Re, G.G., Hazen-Martin, D.J., Sens, D.A. and Garvin, A.J. (1993) WT1-mutated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science, 262, 2057-2059.
33. Hard, G.C. (1984) Tumor biology. In vitro culture and transplantation models of Wilms' tumor. Pochedly, C. and Baum, E.S. (eds), Wilms' Tumor Clinical and Biological Manifestations, Elsevier, New York, Amsterdam, Oxford, pp. 191-214.
34. Dekel, B., Metsuyanim, S., Schmidt-Ott, K.M., Fridman, E., Jacob-Hirsch, J., Simon, A., Pinthus, J., Mor, Y., Barasch, J., Amariglio, N. et al. (2006) Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res., 66, 6040-6049.
35. Nagashima, Y., Nishihira, H., Miyagi, Y., Tanaka, Y., Sasaki, Y., Nishi, T., Imaizumi, K., Aoki, I. and Misugi, K. (1996) A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoallelic partial deletion of chromosome 11p. Cancer, 77, 799-804.
36. Uschkereit, C., Perez, N., de Torres, C., Küff, M., Mora, J. and Royer-Pokora, B. (2007) Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumors in a patient with a novel germ-line WT1 mutation. J. Med. Genet., 44, 393-396.
37. Scott, R.H., Stiller, C.A., Walker, L. and Rahman, N. (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J. Med. Genet., 43, 705-714.
38. Barberi, T., Willis, L.M., Socci, N.D. and Studer, L. (2005) Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med., 2, 554-560.
39. Shiraki, N., Higuchi, Y., Harada, S., Umeda, K., Isagawa, T., Aburatani, H., Kume, K. and Kume, S. (2009) Differentiation and characterization of embryonic stem cells into three germ layers. Biochem. Biophys. Res. Com., 381, 694-699.
40. Brunskill, E.W., Aronow, B.J., Georgas, K., Rumballe, B., Valerius, M.T., Aronow, J., Kaimal, V., Jegga, A.G., Grimmond, S., McMahon, A.P. et al. (2008) Atlas of gene expression in the developing kidney at microanatomic resolution. Dev. Cell, 15, 781-791.
41. Wellik, D., Hawkes, J. and Capecci, M.R. (2002) Hox11 paralogous genes are essential for metanephric kidney induction. Genes Dev., 16, 1423-1432.
42. Epping, M.T. and Bernards, R. (2006) A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res., 66, 10639-10642.
43. Fukuzawa, R., Anaka, M.R., Weeks, R.J., Morison, I.M. and Reeve, A.E. (2009) Canonical WNT signalling determines lineage specificity in Wilms tumour. Oncogene, 28, 1063-1075.
44. Corbin, M., de Reyniès, A., Rickman, D.S., Berrebi, D., Boccon-Gibod, L., Cohen-Gogo, S., Fabre, M., Jaubert, F., Faussillon, M., Yilmaz, F. et al. (2009) WNT/b-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes Chromosomes Cancer, 48, 816-827.
45. Zirn, B., Samans, B., Wittmann, S., Pietsch, T., Leuschner, I., Graf, N. and Gessler, M. (2006) Target genes of the WNT/β-catenin pathway in Wilms tumors. Genes Chromosomes Cancer, 45, 565-574.
46. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D. and Jaenisch, R. (1993) WT-1 is required for early kidney development. Cell, 74, 679-691.
47. Davis, J.A., Ladomery, M., Hohenstein, P., Michael, L., Shafe, A., Spraggon, L. and Hastie, N. (2004) Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum. Mol. Genet., 13, 235-246.
48. Gang, E.J., Bosnakovski, D., Simsek, T., To, K. and Perlingeiro, R.C.R. (2008) Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp. Cell Res., 314, 1721-1733.
49. Ridgeway, A.G. and Skerjanc, I.S. (2001) Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2. J. Biol. Chem., 276, 19033-19039.
50. Hueber, P.A., Fukuzawa, R., El-Kares, R., Chu, L.L., Blumenkrantz, M., He, S., Anaka, M.R., Reeve, A.E., Eccles, M.R., Jabado, N. et al. (2008) PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenetic phenotype. Pediatr. Dev. Pathol., (Epub ahead of print) Published Online: 1 August 2008, doi: 10.2350/08-05-0466.1.
51. Iglesias, D.M., Hueber, P.-A., Chu, L.L., Campbell, R., Patenaude, A.-M., Dziarmaga, A.J., Quinlan, J., Mohamed, O., Dufort, D. and Goodyer, P.R. (2007) Canonical WNT signaling during kidney development. Am. J. Physiol. Renal Physiol., 293, F494-F500.
52. Schmidt-Ott, K.M. and Barasch, J. (2008) Wnt/β-catenin signalling in nephron progenitors and their epithelial progeny. Kidney Int., 74, 1004-1008.
53. Park, J., Valerius, M. and McMahon, A. Wnt/β-catenin signaling regulates nephron induction during mouse kidney development. Development, 134, 2533-2539.
54. Roszko, I., Sawada, A. and Solnica-Krezel, L. (2009) Regulation of convergence and extension movements during vertebrate gastrulation by the Wnt/PCP pathway. Semin. Cell Dev. Biol., doi:10.1016/j.semcdb.2009.09.004.
55. Sweetman, D., Wagstaff, L., Cooper, O., Weijer, C. and Münsterberg, A. (2008) The migration of paraxial and lateral plate mesoderm cells emerging from the late plate primitive streak is controlled by different Wnt signals. BMC Dev. Biol., 8, 63.
56. Kim, M.K.-H., McGarry, T.J., Broin, P., Flatow, J.M., Golden, A.A.-J. and Licht, J.D. (2009) An integrated genome screen identifies the Wnt signalling pathway as a major target of WT1. Proc. Natl Acad. Sci. USA, 106, 11154-11159.
57. Smyth, G.K. (2005) Limma: linear models for microarray data. Gentleman, R., Carey, V., Dudoit, S., Irizarry, R. and Huber, W. (eds), Bioinformatics and Computational Biology Solutions using R and Bioconductor, Springer, New York, pp. 397-420.
58. Goeman, J.J., van de Geer, S.A., de Kort, F. and van Houwelingen, H.C. (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics, 20, 93-99.
59. Goeman, J.J., Oosting, J., Cleton-Jansen, A.-M., Anninga, J.K. and van Houwelingen, H.C. (2005) Testing association of a pathway with survival. Bioinformatics, 21, 1950-1957.
60. Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N.,Braisted, J., Klapa, M., Currier, T., Thiagarajan, M. et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques, 34, 374-378.